Occult ectopic ACTH secretion due to recurrent lung carcinoid: Long- term control of hypercortisolism by continuous subcutaneous infusion of octreotide

Clinical Endocrinology

Volumn 49, Issue 4, 1998, Pages 541-546

  Van Den Bruel, A ^a   Bex, M ^a   Van Dorpe, J ^a   Heyns, W ^a   Bouillon, R ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; HYDROCORTISONE; HYDROXYCORTICOSTEROID; OCTREOTIDE;

ADULT; ARTICLE; CANCER SURGERY; CARCINOID; CASE REPORT; CONTINUOUS INFUSION; DEXAMETHASONE SUPPRESSION TEST; ECTOPIC CORTICOTROPIN PRODUCTION; FEMALE; HUMAN; HYPERCORTISOLISM; LONG TERM CARE; LUNG TUMOR; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR RECURRENCE;

EID: 0031720091     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1998.00510.x     Document Type: Article

References (32)

1. Aron, D.C., Raff, H. & Findling, J.W. (1997) Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethusone suppression testing in the differential diagnosis of adrenoconicotropin-dependent Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism, 82, 1780-1785.
2. Becker, M. & Aron, D.C. (1994) Ectopic ACTH syndrome and CRH-mediated Cushing's syndrome. Endocrinology and metabolism clinics of North America, 23, 585-605.
3. Bertagna, X., Favrod-Coune, C., Escourelle, H., Beuzeboc, P., Christoforov, B., Girard, F. & Luton, J.-P. (1989) Suppression of ectopic adrenocorticotropin secretion by the long-acting somatostatin analog octreotide. Journal of Endocrinology and Metabolism, 68, 988-991.
4. Bertherat, J. (1996) Ectopic expression of the pituitary V3 vasopressin receptor reveals new aspects of the ectopic ACTH syndrome. European Journal of Endocrinology, 135, 173-174.
5. Brown, W. (1928) A case of Pluriglandular syndrome: 'Diabetes of Bearded Women.' Lancet. 2, 1022-1023.
6. Cheung, N. W. & Boyages, S.C. (1992) Failure of somatostatin analogue to control Cushing's syndrome in two cases of ACTH producing carcinoid tumours. Clinical Endocrinology, 36, 361-367.
7. Coolens, J.L., Van Baelen, H. & Heyns, W. (1987) Clinical use of unbound plasma Cortisol as calculated from total cortisol and corticosteroid-binding globulin. The Journal of Steroid Biochemistry, 26, 197-202.
8. Dash, R.J., England, B.G., Midgley, A.R. & Niswender, G.D. (1975) A specific, non chromatographc; radioimmunoassay for human plasma cortisol. Steroids, 26, 647-661.
9. De Herder, W.W., Krenning, E.P., Malchoff, C.D., Hofland, L.J., Reubi, J.C., Kwekkeboom, D.J., Yoe Oei, H., Puls, H.A.P., Bruining, A., Nobels, F.R.E. & Lamberts, S.W.J. (1994) Somatostatin receptor scintigraphy: Its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion. The American Journal of Medicine, 96, 305-312.
10. De Keyzer, Y., Lenne, F., Auzan, C., Jégou, S., René, P., Vaudry, H., Kuhn, J.-M., Luton, J.-P., Clauser, E. & Bertagna, X. (1996) The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome. Journal of Clinical Investigation, 97, 1311-1318.
11. Deck, K.A., Fberlein, L., Vetter, H. & Hillen, H. (1976) Die Bestimmung von freien Cortisol in Urin. Deutsche Medizinische Wochenschrift, 101, 818-821.
12. Findling, J.W. & Blake Tyrrell, J.B. (1986) Occult ectopic secretion of corticotropin. Archives of Internal Medicine, 146, 929-933.
13. Hale, A.C., Millar, J.B.G., Ratter, S.J., Pickard, J.D., Doniach, I. & Rees, L.H. (1985) A case of pituitary dependent Cushing's disease with clinical and biochemical features of the ectopic ACTH syndrome. Clinical Endocrinology, 22, 479-488.
14. Hearn, P.R., Reynolds, C.L., Johansen, K. & Woodhouse, N.J.Y. (1988) Lung carcinoid with Cushing's syndrome: control of serum ACTH and cortisol levels using SMS 201-995 (Sandostatin). Clinical Endocrinology, 28, 181-185.
15. Howlett, T.A., Drury, P.L., Perry, L., Doniach. I., Rees, L.H. & Besser, G.M. (1986) Diagnosis and management of ACTH-dependent Cushing's syndrome: comparison of the features in ectopic and piluitary ACTH production. Clinical Endocrinology, 24, 699-713.
16. Invitti, C., De Martin, M., Brununi, A., Piolini, M. & Cavagnini, F. (1990) Treatment of Cushing's syndrome with the long-acting somatostatin analogue SMS 201-995 (sandostatin). Clinical Endocrinology, 32, 275-281.
17. Johansen, K., Reid, K. & Woodhouse, N. (1988) Acute ACTH-lowering effect of SM201-995 (Sandostatin () in a patient with Cushing's syndrome due to ectopic ACTH-producing lung carcinoid. Saudi Medical Journal, 9, 512-514.
18. Lamberts, S.W., Krenning, E.P. & Reubi, J.C. (1991) The role of somatostatin and its analogues in the diagnosis and treatment of tumors. Endocrine Reviews, 12, 450-482
19. Liddle, G.W., Givens, J.R.. Nicholson, W.E. & Island, D.P. (1965) The ectopic ACTH syndrome. Cuncer Research, 25, 1057-1061.
20. Limper, A.H., Carpenter, P.C., Scheithauer, B. & Staats, B.A. (1992) The Cushing syndrome induced by bronchial carcinoid tumors. Annals of Internal Medicine, 117, 209-214.
21. Lorecy, Y., Delambre, C, Le Guerrier, A.M., Le Moullec, N. & Allannic, H. (1991) Use of long-acting somatostatin analog octreotide (SMS 201-995) in the treatment of Cushing's syndrome. Journal of Endocrinological Investigation, 14, 121.
22. Metcalf, M.G. (1966) Quantitative analysis of urinary 17-oxygenic steroids using sodium metaperiodate oxidation. Clinical Chemistry, 12, 258-262.
23. Oldfield, E.H., Doppman, J.L., Nieman, L.K., Chrousos, G.P., Miller, D.L., Katz, D.A., Cutler, G.B. & Loriaux, D.L. (1991) Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. New England Journal of Medicine, 325, 897-905.
24. Pass, H.I., Doppman, J.L., Nieman, L., Stovroff, M., Vetto, J., Norton, J.A., Travis, W., Chrousos, G.P., Oldfield, E.H. & Cutler, G.B. (1990) Management of the ectopic ACTH syndrome due to thoracic carcinoids. Annals of Thoracic Surgery, 50, 52-57.
25. Phlipponeau, M., Nocaudie, M., Epelbaum, J., De Keyler, Y., Lalau, J.D., Marchandise, X. & Bertagna, X. (1994) Somatostatin analogs for the localization and preoperative treatment of an ACTH secreting bronchial carcinoid tumor. Journal of Clinical Endocrinology and Metabolism. 78, 20-24.
26. Rafrin-Sanson, M.L., Massias, J.F., Dumont, C., Raux-Demay M.C.. Proeschel, M.F., Luton, J.P. & Bertagna, X. (1996) High plasma proopiomelanocortin in aggressive adrenocorticotropin-sccreting tumors. Journal of Clinical Endocrinology and Metabolism, 81, 4272-4277.
27. Reubi, J.C., Kvols, L.K., Waser, B., Nagorney, D.M., Heitz, P.U., Charboneau, J.W., Reading, C.C. & Moertel, C. (1990) Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Research, 50, 5969-5977.
28. Rieu, M., Rosilio, M., Richard, A., Vannetzel, J.-M. & Kuhn, J.-M. (1993) Paradoxical effect of somatostatin analogues on the ectopic secretion of corticotropin in two cases of small cell lung carcinoma. Hormone Research, 39, 207-212.
29. Van Hemelrijck, J., Weckers, F., Van Aken, H., Bouillon, R. & Heyns, W. (1995) Propofol anesthesia does not inhibit stimulation of cortisol synthesis. Anesthesia and Analgesia, 80, 573-576.
30. Wajchenberg, B.L., Mendonca, B.B., Liberman, B., Pereira, M.A.A. & Kirschner, A. (1995) Ectopic ACTH syndrome. The Journal of Steroid Biochemistry and Molecular Biology, 53, 139-151.
31. von Werder, K., Muller, O.A. & Stalla, G.K. (1996) Somatostatin analogs in ectopic corticotropin production. Metabolism, 45, 129-131.
32. Woodhouse, N.J., Dagogo-Jack, S., Ahmed, M. & Judzewitsch, R. (1993) Acute and long term effects of octreotide in patients with ACTH dependent Cushing's syndrome. American Journal of Medicine, 95, 305-308.